US Stock MarketDetailed Quotes

PMCB PharmaCyte Biotech

Watchlist

1.740
0.0000.00%

Close Nov 5 16:00 ET

1.730
-0.010-0.57%

Post 17:24 ET

13.36MMarket Cap2.72P/E (TTM)

PharmaCyte Biotech Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Jul 31, 2024

(FY)Apr 30, 2024

(Q4)Apr 30, 2024

(Q3)Jan 31, 2024

(Q2)Oct 31, 2023

(Q1)Jul 31, 2023

(FY)Apr 30, 2023

(Q4)Apr 30, 2023

(Q3)Jan 31, 2023

(Q2)Oct 31, 2022

Assets

Current assets

Cash, cash equivalents and short term investments

-56.29%32.64M

-26.25%50.18M

-15.73%61.21M

-4.60%73.43M

-9.20%74.66M

-20.33%68.04M

-16.16%72.64M

-11.47%76.96M

-Cash and cash equivalents

-56.29%32.64M

-26.25%50.18M

-15.73%61.21M

-4.60%73.43M

-9.20%74.66M

-20.33%68.04M

-16.16%72.64M

-11.47%76.96M

Prepaid assets

----

6.21%256.81K

Other current assets

170.98%240.23K

141.27%259.8K

64.50%297.76K

--323.19K

--88.65K

--107.68K

--181.01K

----

Total current assets

-56.02%32.88M

-25.98%50.44M

-15.54%61.51M

-4.49%73.75M

-9.12%74.75M

-20.29%68.15M

-16.12%72.82M

-11.43%77.22M

Non current assets

Goodwill and other intangible assets

-56.35%1.55M

0.00%3.55M

-Other intangible assets

----

--1.55M

0.00%3.55M

----

0.00%3.55M

Investments and advances

1,752.19%29.12M

--0

0.00%1.57M

Long-term notes receivables

--3M

--2.76M

--2.01M

----

--0

----

Financial assets

--3.64M

--5.15M

--2.71M

----

--0

----

Other non current assets

0.00%7.69K

Total non current assets

627.57%37.32M

84.51%9.46M

92.06%9.85M

0.00%5.13M

Total assets

-12.13%70.19M

-18.25%59.9M

-8.46%71.36M

-4.21%78.88M

-8.59%79.88M

-19.14%73.28M

-15.22%77.95M

-10.79%82.35M

Liabilities

Current liabilities

Payables

-13.15%901.45K

291.38%729.44K

8.58%484.2K

-85.35%126.16K

85.68%1.04M

-9.24%186.38K

380.22%445.94K

448.45%861.28K

-accounts payable

-22.86%553.95K

203.53%389.37K

8.58%484.2K

-85.35%126.16K

28.46%718.13K

-37.53%128.28K

380.22%445.94K

448.45%861.28K

-Total tax payable

--347.49K

485.36%340.07K

----

--58.1K

----

-Dividends payable

----

--319.85K

----

Current accrued expenses

-29.87%336.64K

-1.27%395.13K

102.79%774.44K

126.33%1.02M

-9.48%480.04K

-19.80%400.2K

-26.57%381.9K

1,446.80%449.86K

Other current liabilities

--6.23M

--6.3M

--6.28M

--4.1M

----

Current liabilities

392.28%7.47M

1,165.17%7.42M

810.66%7.54M

299.62%5.24M

39.35%1.52M

-16.72%586.58K

35.05%827.83K

604.45%1.31M

Non current liabilities

Derivative product liabilities

-48.73%9.68M

--12.97M

--14.93M

--15.57M

--18.88M

--0

----

Total non current liabilities

-48.73%9.68M

--12.97M

--14.93M

--15.57M

--18.88M

--0

Total liabilities

-15.90%17.15M

3,375.95%20.39M

2,613.80%22.47M

1,487.38%20.81M

1,772.39%20.4M

-16.72%586.58K

35.05%827.83K

604.45%1.31M

Shareholders'equity

Share capital

-68.16%5.34M

549,399.21%11.87M

811,051.25%17.52M

986,003.52%21.3M

775,605.65%16.76M

4.25%2.16K

-common stock

0.00%2.17K

0.32%2.17K

4.25%2.16K

-Preferred stock

-68.17%5.33M

--11.87M

--17.52M

--21.3M

--16.75M

--0

----

Retained earnings

22.82%-92.2M

0.29%-115.63M

-0.98%-116.97M

-1.11%-116.35M

-5.54%-119.46M

-3.86%-115.96M

-5.09%-115.84M

-5.17%-115.07M

Paid-in capital

-9.65%182.72M

-8.36%185.33M

-6.43%189.22M

-3.97%193.59M

0.32%202.23M

0.33%202.23M

0.02%201.6M

Less: Treasury stock

6.93%42.79M

210.02%42.04M

341.47%40.85M

638.68%40.45M

1,813.96%40.02M

--13.56M

--9.25M

--5.48M

Gains losses not affecting retained earnings

-3.44%-23.33K

-2.21%-23.51K

-30.16%-23.07K

-59.12%-24.14K

-56.04%-22.55K

-45.99%-23K

8.16%-17.73K

20.52%-15.17K

Total stockholders'equity

-10.83%53.04M

-45.64%39.51M

-36.60%48.89M

-28.35%58.07M

-31.07%59.48M

-19.16%72.69M

-15.56%77.12M

-12.03%81.04M

Total equity

-10.83%53.04M

-45.64%39.51M

-36.60%48.89M

-28.35%58.07M

-31.07%59.48M

-19.16%72.69M

-15.56%77.12M

-12.03%81.04M

Currency Unit

USD

Audit Opinions

Unqualified Opinion

	(Q1)Jul 31, 2024	(FY)Apr 30, 2024	(Q4)Apr 30, 2024	(Q3)Jan 31, 2024	(Q2)Oct 31, 2023	(Q1)Jul 31, 2023	(FY)Apr 30, 2023	(Q4)Apr 30, 2023	(Q3)Jan 31, 2023	(Q2)Oct 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments	-56.29%32.64M	-26.25%50.18M	-26.25%50.18M	-15.73%61.21M	-4.60%73.43M	-9.20%74.66M	-20.33%68.04M	-20.33%68.04M	-16.16%72.64M	-11.47%76.96M
-Cash and cash equivalents	-56.29%32.64M	-26.25%50.18M	-26.25%50.18M	-15.73%61.21M	-4.60%73.43M	-9.20%74.66M	-20.33%68.04M	-20.33%68.04M	-16.16%72.64M	-11.47%76.96M
Prepaid assets	----	----	----	----	----	----	----	----	----	6.21%256.81K
Other current assets	170.98%240.23K	141.27%259.8K	141.27%259.8K	64.50%297.76K	--323.19K	--88.65K	--107.68K	--107.68K	--181.01K	----
Total current assets	-56.02%32.88M	-25.98%50.44M	-25.98%50.44M	-15.54%61.51M	-4.49%73.75M	-9.12%74.75M	-20.29%68.15M	-20.29%68.15M	-16.12%72.82M	-11.43%77.22M
Non current assets
Goodwill and other intangible assets	-56.35%1.55M	-56.35%1.55M	-56.35%1.55M	0.00%3.55M	0.00%3.55M	0.00%3.55M	0.00%3.55M	0.00%3.55M	0.00%3.55M	0.00%3.55M
-Other intangible assets	----	--1.55M	--1.55M	0.00%3.55M	0.00%3.55M	0.00%3.55M	----	----	0.00%3.55M	0.00%3.55M
Investments and advances	1,752.19%29.12M	--0	--0	0.00%1.57M	0.00%1.57M	0.00%1.57M	0.00%1.57M	0.00%1.57M	0.00%1.57M	0.00%1.57M
Long-term notes receivables	--3M	--2.76M	--2.76M	--2.01M	----	----	--0	--0	----	----
Financial assets	--3.64M	--5.15M	--5.15M	--2.71M	----	----	--0	--0	----	----
Other non current assets	0.00%7.69K	0.00%7.69K	0.00%7.69K	0.00%7.69K	0.00%7.69K	0.00%7.69K	0.00%7.69K	0.00%7.69K	0.00%7.69K	0.00%7.69K
Total non current assets	627.57%37.32M	84.51%9.46M	84.51%9.46M	92.06%9.85M	0.00%5.13M	0.00%5.13M	0.00%5.13M	0.00%5.13M	0.00%5.13M	0.00%5.13M
Total assets	-12.13%70.19M	-18.25%59.9M	-18.25%59.9M	-8.46%71.36M	-4.21%78.88M	-8.59%79.88M	-19.14%73.28M	-19.14%73.28M	-15.22%77.95M	-10.79%82.35M
Liabilities
Current liabilities
Payables	-13.15%901.45K	291.38%729.44K	291.38%729.44K	8.58%484.2K	-85.35%126.16K	85.68%1.04M	-9.24%186.38K	-9.24%186.38K	380.22%445.94K	448.45%861.28K
-accounts payable	-22.86%553.95K	203.53%389.37K	203.53%389.37K	8.58%484.2K	-85.35%126.16K	28.46%718.13K	-37.53%128.28K	-37.53%128.28K	380.22%445.94K	448.45%861.28K
-Total tax payable	--347.49K	485.36%340.07K	485.36%340.07K	----	----	----	--58.1K	--58.1K	----	----
-Dividends payable	----	----	----	----	----	--319.85K	----	----	----	----
Current accrued expenses	-29.87%336.64K	-1.27%395.13K	-1.27%395.13K	102.79%774.44K	126.33%1.02M	-9.48%480.04K	-19.80%400.2K	-19.80%400.2K	-26.57%381.9K	1,446.80%449.86K
Other current liabilities	--6.23M	--6.3M	--6.3M	--6.28M	--4.1M	----	----	----	----	----
Current liabilities	392.28%7.47M	1,165.17%7.42M	1,165.17%7.42M	810.66%7.54M	299.62%5.24M	39.35%1.52M	-16.72%586.58K	-16.72%586.58K	35.05%827.83K	604.45%1.31M
Non current liabilities
Derivative product liabilities	-48.73%9.68M	--12.97M	--12.97M	--14.93M	--15.57M	--18.88M	--0	--0	----	----
Total non current liabilities	-48.73%9.68M	--12.97M	--12.97M	--14.93M	--15.57M	--18.88M	--0	--0	--0	--0
Total liabilities	-15.90%17.15M	3,375.95%20.39M	3,375.95%20.39M	2,613.80%22.47M	1,487.38%20.81M	1,772.39%20.4M	-16.72%586.58K	-16.72%586.58K	35.05%827.83K	604.45%1.31M
Shareholders'equity
Share capital	-68.16%5.34M	549,399.21%11.87M	549,399.21%11.87M	811,051.25%17.52M	986,003.52%21.3M	775,605.65%16.76M	4.25%2.16K	4.25%2.16K	4.25%2.16K	4.25%2.16K
-common stock	0.00%2.17K	0.32%2.17K	0.32%2.17K	0.32%2.17K	0.32%2.17K	0.32%2.17K	4.25%2.16K	4.25%2.16K	4.25%2.16K	4.25%2.16K
-Preferred stock	-68.17%5.33M	--11.87M	--11.87M	--17.52M	--21.3M	--16.75M	--0	--0	----	----
Retained earnings	22.82%-92.2M	0.29%-115.63M	0.29%-115.63M	-0.98%-116.97M	-1.11%-116.35M	-5.54%-119.46M	-3.86%-115.96M	-3.86%-115.96M	-5.09%-115.84M	-5.17%-115.07M
Paid-in capital	-9.65%182.72M	-8.36%185.33M	-8.36%185.33M	-6.43%189.22M	-3.97%193.59M	0.32%202.23M	0.32%202.23M	0.32%202.23M	0.33%202.23M	0.02%201.6M
Less: Treasury stock	6.93%42.79M	210.02%42.04M	210.02%42.04M	341.47%40.85M	638.68%40.45M	1,813.96%40.02M	--13.56M	--13.56M	--9.25M	--5.48M
Gains losses not affecting retained earnings	-3.44%-23.33K	-2.21%-23.51K	-2.21%-23.51K	-30.16%-23.07K	-59.12%-24.14K	-56.04%-22.55K	-45.99%-23K	-45.99%-23K	8.16%-17.73K	20.52%-15.17K
Total stockholders'equity	-10.83%53.04M	-45.64%39.51M	-45.64%39.51M	-36.60%48.89M	-28.35%58.07M	-31.07%59.48M	-19.16%72.69M	-19.16%72.69M	-15.56%77.12M	-12.03%81.04M
Total equity	-10.83%53.04M	-45.64%39.51M	-45.64%39.51M	-36.60%48.89M	-28.35%58.07M	-31.07%59.48M	-19.16%72.69M	-19.16%72.69M	-15.56%77.12M	-12.03%81.04M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data